nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—OPRD1—coronary artery disease	0.645	1	CbGaD
Pentazocine—Butorphanol—OPRD1—coronary artery disease	0.00209	0.532	CrCbGaD
Pentazocine—Levorphanol—OPRD1—coronary artery disease	0.00184	0.468	CrCbGaD
Pentazocine—Constipation—Telmisartan—coronary artery disease	0.000203	0.000883	CcSEcCtD
Pentazocine—Agitation—Ramipril—coronary artery disease	0.000203	0.000882	CcSEcCtD
Pentazocine—Hypersensitivity—Simvastatin—coronary artery disease	0.000203	0.000882	CcSEcCtD
Pentazocine—Insomnia—Perindopril—coronary artery disease	0.000203	0.000881	CcSEcCtD
Pentazocine—Diarrhoea—Clopidogrel—coronary artery disease	0.000203	0.000881	CcSEcCtD
Pentazocine—Asthenia—Eplerenone—coronary artery disease	0.000203	0.000881	CcSEcCtD
Pentazocine—Diarrhoea—Lovastatin—coronary artery disease	0.000201	0.000875	CcSEcCtD
Pentazocine—Paraesthesia—Perindopril—coronary artery disease	0.000201	0.000875	CcSEcCtD
Pentazocine—Decreased appetite—Captopril—coronary artery disease	0.000201	0.000872	CcSEcCtD
Pentazocine—Anorexia—Losartan—coronary artery disease	0.0002	0.000871	CcSEcCtD
Pentazocine—Nausea—Acetylsalicylic acid—coronary artery disease	0.0002	0.000871	CcSEcCtD
Pentazocine—Pruritus—Eplerenone—coronary artery disease	0.0002	0.000869	CcSEcCtD
Pentazocine—Dyspnoea—Perindopril—coronary artery disease	0.0002	0.000869	CcSEcCtD
Pentazocine—Dizziness—Fenofibrate—coronary artery disease	0.000199	0.000866	CcSEcCtD
Pentazocine—Somnolence—Perindopril—coronary artery disease	0.000199	0.000866	CcSEcCtD
Pentazocine—Feeling abnormal—Trandolapril—coronary artery disease	0.000199	0.000866	CcSEcCtD
Pentazocine—Vertigo—Ramipril—coronary artery disease	0.000198	0.000863	CcSEcCtD
Pentazocine—Feeling abnormal—Enalapril—coronary artery disease	0.000198	0.000862	CcSEcCtD
Pentazocine—Syncope—Ramipril—coronary artery disease	0.000198	0.000861	CcSEcCtD
Pentazocine—Asthenia—Simvastatin—coronary artery disease	0.000197	0.000859	CcSEcCtD
Pentazocine—Diarrhoea—Ezetimibe—coronary artery disease	0.000197	0.000859	CcSEcCtD
Pentazocine—Constipation—Captopril—coronary artery disease	0.000197	0.000858	CcSEcCtD
Pentazocine—Hypotension—Losartan—coronary artery disease	0.000196	0.000854	CcSEcCtD
Pentazocine—Dysgeusia—Lisinopril—coronary artery disease	0.000196	0.000853	CcSEcCtD
Pentazocine—Dizziness—Clopidogrel—coronary artery disease	0.000196	0.000852	CcSEcCtD
Pentazocine—Paraesthesia—Furosemide—coronary artery disease	0.000196	0.000851	CcSEcCtD
Pentazocine—Feeling abnormal—Telmisartan—coronary artery disease	0.000195	0.000851	CcSEcCtD
Pentazocine—Decreased appetite—Perindopril—coronary artery disease	0.000195	0.000847	CcSEcCtD
Pentazocine—Pruritus—Simvastatin—coronary artery disease	0.000195	0.000847	CcSEcCtD
Pentazocine—Dizziness—Lovastatin—coronary artery disease	0.000194	0.000846	CcSEcCtD
Pentazocine—Loss of consciousness—Ramipril—coronary artery disease	0.000194	0.000844	CcSEcCtD
Pentazocine—Vertigo—Timolol—coronary artery disease	0.000194	0.000843	CcSEcCtD
Pentazocine—Somnolence—Furosemide—coronary artery disease	0.000194	0.000842	CcSEcCtD
Pentazocine—Syncope—Timolol—coronary artery disease	0.000193	0.000842	CcSEcCtD
Pentazocine—Diarrhoea—Eplerenone—coronary artery disease	0.000193	0.00084	CcSEcCtD
Pentazocine—Muscle spasms—Lisinopril—coronary artery disease	0.000192	0.000837	CcSEcCtD
Pentazocine—Constipation—Perindopril—coronary artery disease	0.000192	0.000833	CcSEcCtD
Pentazocine—Vomiting—Fenofibrate—coronary artery disease	0.000191	0.000833	CcSEcCtD
Pentazocine—Hypersensitivity—Valsartan—coronary artery disease	0.000191	0.000833	CcSEcCtD
Pentazocine—Dizziness—Ezetimibe—coronary artery disease	0.000191	0.00083	CcSEcCtD
Pentazocine—Feeling abnormal—Captopril—coronary artery disease	0.00019	0.000827	CcSEcCtD
Pentazocine—Insomnia—Losartan—coronary artery disease	0.00019	0.000827	CcSEcCtD
Pentazocine—Dermatitis—Fenofibrate—coronary artery disease	0.00019	0.000825	CcSEcCtD
Pentazocine—Loss of consciousness—Timolol—coronary artery disease	0.00019	0.000825	CcSEcCtD
Pentazocine—Decreased appetite—Furosemide—coronary artery disease	0.000189	0.000824	CcSEcCtD
Pentazocine—Headache—Fenofibrate—coronary artery disease	0.000189	0.000821	CcSEcCtD
Pentazocine—Vision blurred—Lisinopril—coronary artery disease	0.000189	0.000821	CcSEcCtD
Pentazocine—Paraesthesia—Losartan—coronary artery disease	0.000189	0.000821	CcSEcCtD
Pentazocine—Vomiting—Clopidogrel—coronary artery disease	0.000188	0.000819	CcSEcCtD
Pentazocine—Diarrhoea—Simvastatin—coronary artery disease	0.000188	0.000819	CcSEcCtD
Pentazocine—Tremor—Lisinopril—coronary artery disease	0.000188	0.000816	CcSEcCtD
Pentazocine—Dyspnoea—Losartan—coronary artery disease	0.000187	0.000815	CcSEcCtD
Pentazocine—Vomiting—Lovastatin—coronary artery disease	0.000187	0.000813	CcSEcCtD
Pentazocine—Somnolence—Losartan—coronary artery disease	0.000187	0.000813	CcSEcCtD
Pentazocine—Dizziness—Eplerenone—coronary artery disease	0.000187	0.000812	CcSEcCtD
Pentazocine—Dermatitis—Clopidogrel—coronary artery disease	0.000186	0.000811	CcSEcCtD
Pentazocine—Asthenia—Valsartan—coronary artery disease	0.000186	0.000811	CcSEcCtD
Pentazocine—Hypertension—Timolol—coronary artery disease	0.000186	0.000811	CcSEcCtD
Pentazocine—Constipation—Furosemide—coronary artery disease	0.000186	0.00081	CcSEcCtD
Pentazocine—Hypersensitivity—Niacin—coronary artery disease	0.000186	0.00081	CcSEcCtD
Pentazocine—Asthenia—Olmesartan—coronary artery disease	0.000185	0.000807	CcSEcCtD
Pentazocine—Headache—Clopidogrel—coronary artery disease	0.000185	0.000807	CcSEcCtD
Pentazocine—Dermatitis—Lovastatin—coronary artery disease	0.000185	0.000806	CcSEcCtD
Pentazocine—Feeling abnormal—Perindopril—coronary artery disease	0.000185	0.000803	CcSEcCtD
Pentazocine—Headache—Lovastatin—coronary artery disease	0.000184	0.000802	CcSEcCtD
Pentazocine—Pruritus—Valsartan—coronary artery disease	0.000184	0.0008	CcSEcCtD
Pentazocine—Dry mouth—Ramipril—coronary artery disease	0.000184	0.0008	CcSEcCtD
Pentazocine—Vomiting—Ezetimibe—coronary artery disease	0.000183	0.000798	CcSEcCtD
Pentazocine—Hypersensitivity—Pravastatin—coronary artery disease	0.000183	0.000797	CcSEcCtD
Pentazocine—Pruritus—Olmesartan—coronary artery disease	0.000183	0.000796	CcSEcCtD
Pentazocine—Decreased appetite—Losartan—coronary artery disease	0.000183	0.000795	CcSEcCtD
Pentazocine—Dizziness—Simvastatin—coronary artery disease	0.000182	0.000791	CcSEcCtD
Pentazocine—Dermatitis—Ezetimibe—coronary artery disease	0.000182	0.000791	CcSEcCtD
Pentazocine—Confusional state—Ramipril—coronary artery disease	0.000182	0.00079	CcSEcCtD
Pentazocine—Asthenia—Niacin—coronary artery disease	0.000181	0.000788	CcSEcCtD
Pentazocine—Headache—Ezetimibe—coronary artery disease	0.000181	0.000786	CcSEcCtD
Pentazocine—Anaphylactic shock—Ramipril—coronary artery disease	0.00018	0.000784	CcSEcCtD
Pentazocine—Vertigo—Lisinopril—coronary artery disease	0.00018	0.000782	CcSEcCtD
Pentazocine—Dry mouth—Timolol—coronary artery disease	0.00018	0.000782	CcSEcCtD
Pentazocine—Constipation—Losartan—coronary artery disease	0.00018	0.000782	CcSEcCtD
Pentazocine—Syncope—Lisinopril—coronary artery disease	0.000179	0.000781	CcSEcCtD
Pentazocine—Vomiting—Eplerenone—coronary artery disease	0.000179	0.000781	CcSEcCtD
Pentazocine—Feeling abnormal—Furosemide—coronary artery disease	0.000179	0.000781	CcSEcCtD
Pentazocine—Nausea—Fenofibrate—coronary artery disease	0.000179	0.000778	CcSEcCtD
Pentazocine—Pruritus—Niacin—coronary artery disease	0.000179	0.000777	CcSEcCtD
Pentazocine—Asthenia—Pravastatin—coronary artery disease	0.000178	0.000776	CcSEcCtD
Pentazocine—Hypersensitivity—Trandolapril—coronary artery disease	0.000178	0.000774	CcSEcCtD
Pentazocine—Dermatitis—Eplerenone—coronary artery disease	0.000178	0.000774	CcSEcCtD
Pentazocine—Diarrhoea—Valsartan—coronary artery disease	0.000178	0.000773	CcSEcCtD
Pentazocine—Confusional state—Timolol—coronary artery disease	0.000178	0.000773	CcSEcCtD
Pentazocine—Shock—Ramipril—coronary artery disease	0.000177	0.000771	CcSEcCtD
Pentazocine—Hypersensitivity—Enalapril—coronary artery disease	0.000177	0.000771	CcSEcCtD
Pentazocine—Diarrhoea—Olmesartan—coronary artery disease	0.000177	0.00077	CcSEcCtD
Pentazocine—Headache—Eplerenone—coronary artery disease	0.000177	0.000769	CcSEcCtD
Pentazocine—Anaphylactic shock—Timolol—coronary artery disease	0.000176	0.000766	CcSEcCtD
Pentazocine—Pruritus—Pravastatin—coronary artery disease	0.000176	0.000765	CcSEcCtD
Pentazocine—Loss of consciousness—Lisinopril—coronary artery disease	0.000176	0.000765	CcSEcCtD
Pentazocine—Nausea—Clopidogrel—coronary artery disease	0.000176	0.000765	CcSEcCtD
Pentazocine—Tachycardia—Ramipril—coronary artery disease	0.000176	0.000765	CcSEcCtD
Pentazocine—Vomiting—Simvastatin—coronary artery disease	0.000175	0.000761	CcSEcCtD
Pentazocine—Hypersensitivity—Telmisartan—coronary artery disease	0.000175	0.00076	CcSEcCtD
Pentazocine—Nausea—Lovastatin—coronary artery disease	0.000175	0.00076	CcSEcCtD
Pentazocine—Hyperhidrosis—Ramipril—coronary artery disease	0.000174	0.000758	CcSEcCtD
Pentazocine—Dermatitis—Simvastatin—coronary artery disease	0.000173	0.000754	CcSEcCtD
Pentazocine—Asthenia—Trandolapril—coronary artery disease	0.000173	0.000754	CcSEcCtD
Pentazocine—Shock—Timolol—coronary artery disease	0.000173	0.000754	CcSEcCtD
Pentazocine—Feeling abnormal—Losartan—coronary artery disease	0.000173	0.000753	CcSEcCtD
Pentazocine—Diarrhoea—Niacin—coronary artery disease	0.000173	0.000752	CcSEcCtD
Pentazocine—Asthenia—Enalapril—coronary artery disease	0.000173	0.000751	CcSEcCtD
Pentazocine—Headache—Simvastatin—coronary artery disease	0.000172	0.00075	CcSEcCtD
Pentazocine—Dizziness—Valsartan—coronary artery disease	0.000172	0.000747	CcSEcCtD
Pentazocine—Anorexia—Ramipril—coronary artery disease	0.000172	0.000747	CcSEcCtD
Pentazocine—Nausea—Ezetimibe—coronary artery disease	0.000171	0.000745	CcSEcCtD
Pentazocine—Dizziness—Olmesartan—coronary artery disease	0.000171	0.000744	CcSEcCtD
Pentazocine—Pruritus—Trandolapril—coronary artery disease	0.000171	0.000743	CcSEcCtD
Pentazocine—Hyperhidrosis—Timolol—coronary artery disease	0.00017	0.000741	CcSEcCtD
Pentazocine—Asthenia—Telmisartan—coronary artery disease	0.00017	0.000741	CcSEcCtD
Pentazocine—Pruritus—Enalapril—coronary artery disease	0.00017	0.00074	CcSEcCtD
Pentazocine—Diarrhoea—Pravastatin—coronary artery disease	0.00017	0.00074	CcSEcCtD
Pentazocine—Hypotension—Ramipril—coronary artery disease	0.000168	0.000732	CcSEcCtD
Pentazocine—Anorexia—Timolol—coronary artery disease	0.000168	0.00073	CcSEcCtD
Pentazocine—Pruritus—Telmisartan—coronary artery disease	0.000168	0.00073	CcSEcCtD
Pentazocine—Nausea—Eplerenone—coronary artery disease	0.000168	0.00073	CcSEcCtD
Pentazocine—Dizziness—Niacin—coronary artery disease	0.000167	0.000727	CcSEcCtD
Pentazocine—Dry mouth—Lisinopril—coronary artery disease	0.000167	0.000725	CcSEcCtD
Pentazocine—Asthenia—Captopril—coronary artery disease	0.000166	0.00072	CcSEcCtD
Pentazocine—Diarrhoea—Trandolapril—coronary artery disease	0.000165	0.000719	CcSEcCtD
Pentazocine—Vomiting—Valsartan—coronary artery disease	0.000165	0.000719	CcSEcCtD
Pentazocine—Confusional state—Lisinopril—coronary artery disease	0.000165	0.000717	CcSEcCtD
Pentazocine—Diarrhoea—Enalapril—coronary artery disease	0.000165	0.000716	CcSEcCtD
Pentazocine—Hypotension—Timolol—coronary artery disease	0.000165	0.000716	CcSEcCtD
Pentazocine—Dizziness—Pravastatin—coronary artery disease	0.000164	0.000715	CcSEcCtD
Pentazocine—Vomiting—Olmesartan—coronary artery disease	0.000164	0.000715	CcSEcCtD
Pentazocine—Dermatitis—Valsartan—coronary artery disease	0.000164	0.000712	CcSEcCtD
Pentazocine—Nausea—Simvastatin—coronary artery disease	0.000163	0.000711	CcSEcCtD
Pentazocine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000163	0.000711	CcSEcCtD
Pentazocine—Pruritus—Captopril—coronary artery disease	0.000163	0.00071	CcSEcCtD
Pentazocine—Insomnia—Ramipril—coronary artery disease	0.000163	0.000709	CcSEcCtD
Pentazocine—Dermatitis—Olmesartan—coronary artery disease	0.000163	0.000709	CcSEcCtD
Pentazocine—Headache—Valsartan—coronary artery disease	0.000163	0.000708	CcSEcCtD
Pentazocine—Diarrhoea—Telmisartan—coronary artery disease	0.000162	0.000706	CcSEcCtD
Pentazocine—Headache—Olmesartan—coronary artery disease	0.000162	0.000705	CcSEcCtD
Pentazocine—Paraesthesia—Ramipril—coronary artery disease	0.000162	0.000704	CcSEcCtD
Pentazocine—Shock—Lisinopril—coronary artery disease	0.000161	0.000699	CcSEcCtD
Pentazocine—Asthenia—Perindopril—coronary artery disease	0.000161	0.000699	CcSEcCtD
Pentazocine—Dyspnoea—Ramipril—coronary artery disease	0.000161	0.000699	CcSEcCtD
Pentazocine—Vomiting—Niacin—coronary artery disease	0.000161	0.000699	CcSEcCtD
Pentazocine—Hypersensitivity—Furosemide—coronary artery disease	0.00016	0.000698	CcSEcCtD
Pentazocine—Somnolence—Ramipril—coronary artery disease	0.00016	0.000697	CcSEcCtD
Pentazocine—Dizziness—Trandolapril—coronary artery disease	0.00016	0.000695	CcSEcCtD
Pentazocine—Tachycardia—Lisinopril—coronary artery disease	0.000159	0.000694	CcSEcCtD
Pentazocine—Insomnia—Timolol—coronary artery disease	0.000159	0.000693	CcSEcCtD
Pentazocine—Dermatitis—Niacin—coronary artery disease	0.000159	0.000692	CcSEcCtD
Pentazocine—Dizziness—Enalapril—coronary artery disease	0.000159	0.000692	CcSEcCtD
Pentazocine—Pruritus—Perindopril—coronary artery disease	0.000158	0.000689	CcSEcCtD
Pentazocine—Headache—Niacin—coronary artery disease	0.000158	0.000688	CcSEcCtD
Pentazocine—Paraesthesia—Timolol—coronary artery disease	0.000158	0.000688	CcSEcCtD
Pentazocine—Vomiting—Pravastatin—coronary artery disease	0.000158	0.000688	CcSEcCtD
Pentazocine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000158	0.000687	CcSEcCtD
Pentazocine—Diarrhoea—Captopril—coronary artery disease	0.000158	0.000687	CcSEcCtD
Pentazocine—Dyspnoea—Timolol—coronary artery disease	0.000157	0.000683	CcSEcCtD
Pentazocine—Dizziness—Telmisartan—coronary artery disease	0.000157	0.000683	CcSEcCtD
Pentazocine—Dermatitis—Pravastatin—coronary artery disease	0.000157	0.000682	CcSEcCtD
Pentazocine—Decreased appetite—Ramipril—coronary artery disease	0.000157	0.000681	CcSEcCtD
Pentazocine—Somnolence—Timolol—coronary artery disease	0.000157	0.000681	CcSEcCtD
Pentazocine—Asthenia—Furosemide—coronary artery disease	0.000156	0.00068	CcSEcCtD
Pentazocine—Headache—Pravastatin—coronary artery disease	0.000156	0.000678	CcSEcCtD
Pentazocine—Anorexia—Lisinopril—coronary artery disease	0.000156	0.000678	CcSEcCtD
Pentazocine—Hypersensitivity—Losartan—coronary artery disease	0.000155	0.000673	CcSEcCtD
Pentazocine—Nausea—Valsartan—coronary artery disease	0.000154	0.000671	CcSEcCtD
Pentazocine—Pruritus—Furosemide—coronary artery disease	0.000154	0.00067	CcSEcCtD
Pentazocine—Constipation—Ramipril—coronary artery disease	0.000154	0.00067	CcSEcCtD
Pentazocine—Nausea—Olmesartan—coronary artery disease	0.000154	0.000668	CcSEcCtD
Pentazocine—Vomiting—Trandolapril—coronary artery disease	0.000154	0.000668	CcSEcCtD
Pentazocine—Diarrhoea—Perindopril—coronary artery disease	0.000153	0.000667	CcSEcCtD
Pentazocine—Decreased appetite—Timolol—coronary artery disease	0.000153	0.000666	CcSEcCtD
Pentazocine—Vomiting—Enalapril—coronary artery disease	0.000153	0.000665	CcSEcCtD
Pentazocine—Hypotension—Lisinopril—coronary artery disease	0.000153	0.000664	CcSEcCtD
Pentazocine—Dizziness—Captopril—coronary artery disease	0.000153	0.000664	CcSEcCtD
Pentazocine—Dermatitis—Trandolapril—coronary artery disease	0.000152	0.000662	CcSEcCtD
Pentazocine—Dermatitis—Enalapril—coronary artery disease	0.000152	0.000659	CcSEcCtD
Pentazocine—Headache—Trandolapril—coronary artery disease	0.000151	0.000658	CcSEcCtD
Pentazocine—Vomiting—Telmisartan—coronary artery disease	0.000151	0.000656	CcSEcCtD
Pentazocine—Asthenia—Losartan—coronary artery disease	0.000151	0.000656	CcSEcCtD
Pentazocine—Headache—Enalapril—coronary artery disease	0.000151	0.000656	CcSEcCtD
Pentazocine—Nausea—Niacin—coronary artery disease	0.00015	0.000653	CcSEcCtD
Pentazocine—Dermatitis—Telmisartan—coronary artery disease	0.000149	0.00065	CcSEcCtD
Pentazocine—Diarrhoea—Furosemide—coronary artery disease	0.000149	0.000648	CcSEcCtD
Pentazocine—Pruritus—Losartan—coronary artery disease	0.000149	0.000647	CcSEcCtD
Pentazocine—Headache—Telmisartan—coronary artery disease	0.000149	0.000647	CcSEcCtD
Pentazocine—Feeling abnormal—Ramipril—coronary artery disease	0.000148	0.000646	CcSEcCtD
Pentazocine—Dizziness—Perindopril—coronary artery disease	0.000148	0.000644	CcSEcCtD
Pentazocine—Insomnia—Lisinopril—coronary artery disease	0.000148	0.000643	CcSEcCtD
Pentazocine—Nausea—Pravastatin—coronary artery disease	0.000148	0.000643	CcSEcCtD
Pentazocine—Paraesthesia—Lisinopril—coronary artery disease	0.000147	0.000638	CcSEcCtD
Pentazocine—Vomiting—Captopril—coronary artery disease	0.000147	0.000638	CcSEcCtD
Pentazocine—Dyspnoea—Lisinopril—coronary artery disease	0.000146	0.000634	CcSEcCtD
Pentazocine—Dermatitis—Captopril—coronary artery disease	0.000145	0.000632	CcSEcCtD
Pentazocine—Somnolence—Lisinopril—coronary artery disease	0.000145	0.000632	CcSEcCtD
Pentazocine—Feeling abnormal—Timolol—coronary artery disease	0.000145	0.000631	CcSEcCtD
Pentazocine—Headache—Captopril—coronary artery disease	0.000145	0.000629	CcSEcCtD
Pentazocine—Dizziness—Furosemide—coronary artery disease	0.000144	0.000626	CcSEcCtD
Pentazocine—Diarrhoea—Losartan—coronary artery disease	0.000144	0.000625	CcSEcCtD
Pentazocine—Nausea—Trandolapril—coronary artery disease	0.000143	0.000624	CcSEcCtD
Pentazocine—Nausea—Enalapril—coronary artery disease	0.000143	0.000622	CcSEcCtD
Pentazocine—Vomiting—Perindopril—coronary artery disease	0.000142	0.00062	CcSEcCtD
Pentazocine—Decreased appetite—Lisinopril—coronary artery disease	0.000142	0.000618	CcSEcCtD
Pentazocine—Dermatitis—Perindopril—coronary artery disease	0.000141	0.000614	CcSEcCtD
Pentazocine—Nausea—Telmisartan—coronary artery disease	0.000141	0.000613	CcSEcCtD
Pentazocine—Headache—Perindopril—coronary artery disease	0.00014	0.00061	CcSEcCtD
Pentazocine—Constipation—Lisinopril—coronary artery disease	0.00014	0.000608	CcSEcCtD
Pentazocine—Dizziness—Losartan—coronary artery disease	0.000139	0.000604	CcSEcCtD
Pentazocine—Vomiting—Furosemide—coronary artery disease	0.000138	0.000602	CcSEcCtD
Pentazocine—Dermatitis—Furosemide—coronary artery disease	0.000137	0.000597	CcSEcCtD
Pentazocine—Nausea—Captopril—coronary artery disease	0.000137	0.000596	CcSEcCtD
Pentazocine—Headache—Furosemide—coronary artery disease	0.000136	0.000593	CcSEcCtD
Pentazocine—Feeling abnormal—Lisinopril—coronary artery disease	0.000135	0.000586	CcSEcCtD
Pentazocine—Vomiting—Losartan—coronary artery disease	0.000134	0.000581	CcSEcCtD
Pentazocine—Nausea—Perindopril—coronary artery disease	0.000133	0.000579	CcSEcCtD
Pentazocine—Hypersensitivity—Ramipril—coronary artery disease	0.000133	0.000577	CcSEcCtD
Pentazocine—Dermatitis—Losartan—coronary artery disease	0.000132	0.000576	CcSEcCtD
Pentazocine—Headache—Losartan—coronary artery disease	0.000132	0.000573	CcSEcCtD
Pentazocine—Hypersensitivity—Timolol—coronary artery disease	0.00013	0.000565	CcSEcCtD
Pentazocine—Nausea—Furosemide—coronary artery disease	0.000129	0.000563	CcSEcCtD
Pentazocine—Asthenia—Ramipril—coronary artery disease	0.000129	0.000562	CcSEcCtD
Pentazocine—Pruritus—Ramipril—coronary artery disease	0.000127	0.000554	CcSEcCtD
Pentazocine—Asthenia—Timolol—coronary artery disease	0.000126	0.00055	CcSEcCtD
Pentazocine—Nausea—Losartan—coronary artery disease	0.000125	0.000543	CcSEcCtD
Pentazocine—Pruritus—Timolol—coronary artery disease	0.000125	0.000542	CcSEcCtD
Pentazocine—Diarrhoea—Ramipril—coronary artery disease	0.000123	0.000536	CcSEcCtD
Pentazocine—Diarrhoea—Timolol—coronary artery disease	0.00012	0.000524	CcSEcCtD
Pentazocine—Hypersensitivity—Lisinopril—coronary artery disease	0.00012	0.000524	CcSEcCtD
Pentazocine—Dizziness—Ramipril—coronary artery disease	0.000119	0.000518	CcSEcCtD
Pentazocine—Asthenia—Lisinopril—coronary artery disease	0.000117	0.00051	CcSEcCtD
Pentazocine—Dizziness—Timolol—coronary artery disease	0.000116	0.000507	CcSEcCtD
Pentazocine—Pruritus—Lisinopril—coronary artery disease	0.000116	0.000503	CcSEcCtD
Pentazocine—Vomiting—Ramipril—coronary artery disease	0.000115	0.000498	CcSEcCtD
Pentazocine—Dermatitis—Ramipril—coronary artery disease	0.000113	0.000494	CcSEcCtD
Pentazocine—Headache—Ramipril—coronary artery disease	0.000113	0.000491	CcSEcCtD
Pentazocine—Vomiting—Timolol—coronary artery disease	0.000112	0.000487	CcSEcCtD
Pentazocine—Diarrhoea—Lisinopril—coronary artery disease	0.000112	0.000486	CcSEcCtD
Pentazocine—Dermatitis—Timolol—coronary artery disease	0.000111	0.000483	CcSEcCtD
Pentazocine—Headache—Timolol—coronary artery disease	0.00011	0.00048	CcSEcCtD
Pentazocine—Dizziness—Lisinopril—coronary artery disease	0.000108	0.00047	CcSEcCtD
Pentazocine—Nausea—Ramipril—coronary artery disease	0.000107	0.000466	CcSEcCtD
Pentazocine—Nausea—Timolol—coronary artery disease	0.000105	0.000455	CcSEcCtD
Pentazocine—Vomiting—Lisinopril—coronary artery disease	0.000104	0.000452	CcSEcCtD
Pentazocine—Dermatitis—Lisinopril—coronary artery disease	0.000103	0.000448	CcSEcCtD
Pentazocine—Headache—Lisinopril—coronary artery disease	0.000102	0.000445	CcSEcCtD
Pentazocine—Nausea—Lisinopril—coronary artery disease	9.7e-05	0.000422	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—CXCL12—coronary artery disease	1.82e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PPP2CA—coronary artery disease	1.82e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—coronary artery disease	1.82e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—F2—coronary artery disease	1.81e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL2—coronary artery disease	1.81e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL3—coronary artery disease	1.81e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6ST—coronary artery disease	1.8e-05	0.000148	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2R—coronary artery disease	1.79e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SDC1—coronary artery disease	1.79e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUNB—coronary artery disease	1.79e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCD—coronary artery disease	1.78e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—coronary artery disease	1.78e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLCB1—coronary artery disease	1.78e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCE—coronary artery disease	1.76e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—JAK2—coronary artery disease	1.76e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS1—coronary artery disease	1.75e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGB—coronary artery disease	1.75e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—S100B—coronary artery disease	1.75e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—coronary artery disease	1.75e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—C3—coronary artery disease	1.74e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR7—coronary artery disease	1.74e-05	0.000143	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDNRB—coronary artery disease	1.73e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS3—coronary artery disease	1.73e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFBR2—coronary artery disease	1.71e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KITLG—coronary artery disease	1.71e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—THBS1—coronary artery disease	1.71e-05	0.00014	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PSMA6—coronary artery disease	1.69e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PSMB5—coronary artery disease	1.69e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—F2—coronary artery disease	1.68e-05	0.000138	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP3—coronary artery disease	1.67e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT5A—coronary artery disease	1.67e-05	0.000137	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—coronary artery disease	1.67e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGAV—coronary artery disease	1.66e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGT—coronary artery disease	1.66e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KNG1—coronary artery disease	1.65e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—coronary artery disease	1.65e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CREB1—coronary artery disease	1.65e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGTR1—coronary artery disease	1.64e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDNRA—coronary artery disease	1.63e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CYBA—coronary artery disease	1.63e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB1—coronary artery disease	1.63e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DUSP6—coronary artery disease	1.62e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOB—coronary artery disease	1.62e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—coronary artery disease	1.61e-05	0.000133	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6R—coronary artery disease	1.61e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL10—coronary artery disease	1.61e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLG—coronary artery disease	1.6e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—coronary artery disease	1.6e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—JAK2—coronary artery disease	1.59e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLAT—coronary artery disease	1.59e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDN1—coronary artery disease	1.59e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—coronary artery disease	1.58e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—coronary artery disease	1.56e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CSF2—coronary artery disease	1.55e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF1—coronary artery disease	1.55e-05	0.000128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—coronary artery disease	1.54e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCE—coronary artery disease	1.54e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—JAK2—coronary artery disease	1.54e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BDKRB2—coronary artery disease	1.54e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL12—coronary artery disease	1.54e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS1—coronary artery disease	1.54e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—coronary artery disease	1.53e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—S100B—coronary artery disease	1.53e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2—coronary artery disease	1.53e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RPS6KB1—coronary artery disease	1.53e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MEF2C—coronary artery disease	1.53e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6ST—coronary artery disease	1.52e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS3—coronary artery disease	1.52e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUNB—coronary artery disease	1.51e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLCB1—coronary artery disease	1.5e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KITLG—coronary artery disease	1.5e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFBR2—coronary artery disease	1.5e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITGB3—coronary artery disease	1.49e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR7—coronary artery disease	1.47e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT5A—coronary artery disease	1.47e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP3—coronary artery disease	1.47e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—coronary artery disease	1.45e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PPP2CA—coronary artery disease	1.45e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCD—coronary artery disease	1.42e-05	0.000117	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOB—coronary artery disease	1.42e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—coronary artery disease	1.4e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGAV—coronary artery disease	1.4e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KNG1—coronary artery disease	1.4e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—JAK2—coronary artery disease	1.4e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDN1—coronary artery disease	1.39e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—coronary artery disease	1.39e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CREB1—coronary artery disease	1.39e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—coronary artery disease	1.39e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR1—coronary artery disease	1.39e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—C3—coronary artery disease	1.39e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—coronary artery disease	1.38e-05	0.000114	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CSF2—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF1—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6R—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL10—coronary artery disease	1.36e-05	0.000112	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLG—coronary artery disease	1.35e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—coronary artery disease	1.35e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RPS6KB1—coronary artery disease	1.34e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MEF2C—coronary artery disease	1.34e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—coronary artery disease	1.32e-05	0.000109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—coronary artery disease	1.32e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—coronary artery disease	1.32e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGB3—coronary artery disease	1.31e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCE—coronary artery disease	1.3e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—JAK2—coronary artery disease	1.3e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS1—coronary artery disease	1.3e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—S100B—coronary artery disease	1.3e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—coronary artery disease	1.29e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—coronary artery disease	1.29e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS3—coronary artery disease	1.28e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—coronary artery disease	1.28e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—coronary artery disease	1.28e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PPP2CA—coronary artery disease	1.27e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KITLG—coronary artery disease	1.27e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFBR2—coronary artery disease	1.27e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—coronary artery disease	1.27e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK14—coronary artery disease	1.26e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCD—coronary artery disease	1.25e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT5A—coronary artery disease	1.24e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP3—coronary artery disease	1.24e-05	0.000102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ESR1—coronary artery disease	1.23e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—coronary artery disease	1.22e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2—coronary artery disease	1.22e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FN1—coronary artery disease	1.22e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—C3—coronary artery disease	1.22e-05	0.0001	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6ST—coronary artery disease	1.21e-05	9.98e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKBIA—coronary artery disease	1.21e-05	9.9e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOB—coronary artery disease	1.2e-05	9.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—coronary artery disease	1.19e-05	9.76e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—JAK2—coronary artery disease	1.18e-05	9.71e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDN1—coronary artery disease	1.18e-05	9.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—coronary artery disease	1.17e-05	9.61e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KIT—coronary artery disease	1.17e-05	9.59e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—coronary artery disease	1.16e-05	9.55e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—coronary artery disease	1.16e-05	9.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CSF2—coronary artery disease	1.15e-05	9.47e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF1—coronary artery disease	1.15e-05	9.47e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—coronary artery disease	1.14e-05	9.4e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—coronary artery disease	1.13e-05	9.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—coronary artery disease	1.13e-05	9.32e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RPS6KB1—coronary artery disease	1.13e-05	9.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MEF2C—coronary artery disease	1.13e-05	9.31e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—coronary artery disease	1.12e-05	9.21e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GSK3B—coronary artery disease	1.12e-05	9.2e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—coronary artery disease	1.11e-05	9.13e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—coronary artery disease	1.11e-05	9.13e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREB1—coronary artery disease	1.11e-05	9.13e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGB3—coronary artery disease	1.1e-05	9.07e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK14—coronary artery disease	1.1e-05	9.07e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—coronary artery disease	1.09e-05	8.93e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6R—coronary artery disease	1.08e-05	8.91e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ESR1—coronary artery disease	1.08e-05	8.9e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	1.08e-05	8.86e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	1.07e-05	8.82e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2—coronary artery disease	1.07e-05	8.79e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FN1—coronary artery disease	1.07e-05	8.79e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—coronary artery disease	1.07e-05	8.78e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	1.07e-05	8.75e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	1.06e-05	8.74e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	1.06e-05	8.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	1.05e-05	8.66e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	1.03e-05	8.47e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—C3—coronary artery disease	1.03e-05	8.46e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KIT—coronary artery disease	1.02e-05	8.41e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.02e-05	8.35e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	1.01e-05	8.34e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—coronary artery disease	9.82e-06	8.07e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	9.82e-06	8.07e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	9.82e-06	8.07e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—coronary artery disease	9.78e-06	8.04e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—coronary artery disease	9.74e-06	8.01e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREB1—coronary artery disease	9.74e-06	8.01e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—coronary artery disease	9.69e-06	7.96e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—coronary artery disease	9.58e-06	7.88e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—coronary artery disease	9.58e-06	7.88e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—coronary artery disease	9.53e-06	7.83e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6R—coronary artery disease	9.5e-06	7.81e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—coronary artery disease	9.47e-06	7.79e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAK2—coronary artery disease	9.42e-06	7.74e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—coronary artery disease	9.39e-06	7.72e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—coronary artery disease	9.37e-06	7.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	9.33e-06	7.67e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	9.33e-06	7.66e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	9.23e-06	7.58e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ESR1—coronary artery disease	9.15e-06	7.52e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2—coronary artery disease	9.04e-06	7.43e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FN1—coronary artery disease	9.04e-06	7.43e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	9e-06	7.4e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	8.93e-06	7.34e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	8.91e-06	7.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	8.9e-06	7.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KIT—coronary artery disease	8.65e-06	7.11e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—coronary artery disease	8.61e-06	7.08e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	8.59e-06	7.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—coronary artery disease	8.5e-06	6.98e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	8.3e-06	6.82e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	8.3e-06	6.82e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAK2—coronary artery disease	8.26e-06	6.79e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—coronary artery disease	8.23e-06	6.77e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREB1—coronary artery disease	8.23e-06	6.77e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—coronary artery disease	8.23e-06	6.76e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—coronary artery disease	8.17e-06	6.72e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	8.09e-06	6.65e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—coronary artery disease	8.06e-06	6.62e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6R—coronary artery disease	8.03e-06	6.6e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—coronary artery disease	8.01e-06	6.58e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—coronary artery disease	7.92e-06	6.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	7.88e-06	6.48e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—coronary artery disease	7.77e-06	6.39e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	7.54e-06	6.2e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	7.54e-06	6.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	7.53e-06	6.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	7.52e-06	6.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—coronary artery disease	7.28e-06	5.98e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	7.28e-06	5.98e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—coronary artery disease	7.21e-06	5.93e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—coronary artery disease	7.18e-06	5.9e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—coronary artery disease	7.17e-06	5.89e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—coronary artery disease	7.02e-06	5.77e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	6.98e-06	5.74e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAK2—coronary artery disease	6.98e-06	5.73e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	6.84e-06	5.62e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—coronary artery disease	6.82e-06	5.6e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	6.61e-06	5.43e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	6.41e-06	5.26e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	6.37e-06	5.23e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	6.28e-06	5.16e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	6.15e-06	5.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	6.12e-06	5.03e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—coronary artery disease	6.1e-06	5.01e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—coronary artery disease	6.06e-06	4.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—coronary artery disease	5.93e-06	4.88e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—coronary artery disease	5.76e-06	4.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	5.62e-06	4.62e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	5.59e-06	4.59e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	5.51e-06	4.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	5.45e-06	4.48e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	5.17e-06	4.25e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—coronary artery disease	4.83e-06	3.97e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	4.78e-06	3.93e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	4.75e-06	3.9e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	4.66e-06	3.83e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—coronary artery disease	4.45e-06	3.66e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—coronary artery disease	4.23e-06	3.48e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	4.04e-06	3.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—coronary artery disease	3.91e-06	3.21e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—coronary artery disease	3.58e-06	2.94e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—coronary artery disease	3.3e-06	2.71e-05	CbGpPWpGaD
